Next Article in Journal
ProToxin, a Predictor of Protein Toxicity
Previous Article in Journal
Toxigenic Aspergillus Diversity and Mycotoxins in Organic Spanish Grape Berries
Previous Article in Special Issue
Geographic Variation in Venom Proteome and Toxicity Profiles of Chinese Naja atra: Implications for Antivenom Optimization
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxins
Volume 17
Issue 10
10.3390/toxins17100488
toxins-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exploring the Venom Diversity of Australian Taipans: Comparative Characterization of Oxyuranus microlepidotus and Oxyuranus scutellatus

by
Guilherme Gonelli Paz
1,2,
Patrick Jack Spencer
3,
Daniel Carvalho Pimenta
4 and
Emidio Beraldo-Neto
2,*
1
Programa de Pós-Graduação em Ciências—Toxinologia do Instituto Butantan, São Paulo 05503-900, SP, Brazil
2
Laboratory of Biochemistry, Instituto Butantan, São Paulo 05503-900, SP, Brazil
3
Instituto de Pesquisas Energéticas e Nucleares, São Paulo 05508-000, SP, Brazil
4
Laboratório de Ecologia e Evolução, Instituto Butantan, São Paulo 05503-900, SP, Brazil
*
Author to whom correspondence should be addressed.
Toxins 2025, 17(10), 488; https://doi.org/10.3390/toxins17100488
Submission received: 27 August 2025 / Revised: 24 September 2025 / Accepted: 25 September 2025 / Published: 1 October 2025
(This article belongs to the Special Issue Animal Venoms: Unraveling the Molecular Complexity (2nd Edition))
Browse Figures
Versions Notes

Abstract

The genus Oxyuranus, which includes some of the most venomous snakes in the world, presents a complex venom composition with potent neurotoxic and procoagulant effects. This study provides a comparative proteomic analysis of the venom of Oxyuranus microlepidotus (Inland Taipan) and Oxyuranus scutellatus (Coastal Taipan), aiming to elucidate the molecular basis underlying their distinct toxicological profiles. Using high-resolution chromatographic fractionation and LC-MS/MS, we identified a core set of nine protein families shared between both species, including phospholipases A2 (PLA2), three-finger toxins (3FTx), natriuretic peptides (NTP), nerve growth factors (NGF), and prothrombin activators (PTA). O. microlepidotus venom exhibited greater diversity of 3FTxs and unique protein families, such as Waprin and 5′-nucleotidases, suggesting lineage-specific functional adaptations. Quantitative analysis revealed a greater relative abundance of PLA2s in O. scutellatus (66%) compared to O. microlepidotus (47%), whereas 3FTXs were more prominent in O. microlepidotus (33% vs. 9%). These interspecific differences likely underlie the distinct clinical manifestations of envenomation and reflect evolutionary divergence in the venom composition. Our findings provide molecular insights into taipan venom complexity and highlight novel toxin candidates with potential biomedical applications in neurobiology, hemostasis, and anti-infective therapy.
Keywords:
taipan venom; proteomics; Oxyuranus scutellatus; Oxyuranus microlepidotus; Inlant Taipan; Coastal Taipan
Key Contribution: Comprehensive comparative proteomic analysis of Oxyuranus microlepidotus and Oxyuranus scutellatus venoms reveals nine shared protein families and highlights striking quantitative and qualitative differences—such as elevated PLA2 in O. scutellatus (66% vs. 47%) and enriched 3FTx in O. microlepidotus (33% vs. 9%)—suggesting an evolutionary basis for the higher lethality of the Inland Taipan. The unique presence of Waprin and 5′-nucleotidase in O. microlepidotus venom further supports its distinct molecular profile and unveils promising candidates for therapeutic exploration in neurobiology, antimicrobial strategies, and hemostasis.

1. Introduction

Australia is widely known for its biodiversity, especially regarding the presence of venomous and poisonous animals, including snakes [1,2,3]. Among the main snake families found on Australian territory, the Elapidae family stands out, whose members are known for their highly toxic venoms, with emphasis on the Oxyuranus genus, which includes the most venomous snakes in the world [3,4,5,6,7]. The main representatives of this genus include O. scutellatus scutellatus (Coastal Taipan), O. microlepidotus (Inland Taipan), O. temporalis (Central Ranges Taipan) and O. scutellatus canni (Papuan Taipan), the latter being found outside Australian territory [8,9,10].
Clinically, envenomation by snakes of the Oxyuranus genus is characterized by a set of neurotoxic and cytotoxic manifestations, including thrombocytopenia, rhabdomyolysis, acute kidney injury, and descending paralysis, which may progress to respiratory failure [7,11,12]. These clinical manifestations result from the action of various toxins present in the venom of these snakes, with taipoxin being one of the main neurotoxic components. Belonging to the phospholipase A2 family, this toxin induces paralysis by causing neurotransmitter depletion at motor nerve terminals [13,14,15,16,17]. Additionally, taipoxin exerts myotoxic effects through the hydrolysis of muscle fiber membranes [17].
Alongside taipoxin, taipotoxin, another toxin present in taipan venom, contributes to neurotoxic effects by blocking voltage-gated calcium channels (CaV), interfering with neurotransmission [18,19,20]. Several other toxins have been characterized in the venom of these animals, including natriuretic toxins, associated with nephrotoxic effects; prothrombin activators, responsible for coagulopathic disorders; and multiples phospholipases A2 [21,22,23,24]. Despite the similarity of compounds found in the venom of these taipan species, studies indicate that lethality varies between species [25,26]. Evidence suggests that O. microlepidotus has higher lethality compared to other taipan species and is considered the most venomous snake in the world. Nevertheless, its venom remains relatively underexplored, with few studies focused on its composition.
Several studies have investigated the venom composition of Oxyuranus species, employing chromatographic profiling, mass analyses, and assessment of molecular activity [8,27,28]. Nevertheless, only one study, conducted by Herrera et al. [22], has provided a comprehensive characterization of the venom of O. scutellatus scutellatus, in comparison with that of O. scutellatus canni, a subspecies found in Papua New Guinea. This study revealed a range of shared venom components between two species; however, significant quantitative differences were observed, which may account for the variation in toxicity reported between them.
Given the high specificity and potency of snake venom toxins, characterizing these molecules may also yield candidates for therapeutic development or molecular tools to study physiological processes, particularly in neurobiology and hemostasis.
Therefore, this study aims to characterize the venom of O. microlepidotus using proteomic approaches and compare it with the venom of O. scutellatus. We hypothesize that compositional differences between these species may underlie the distinct clinical outcomes of envenomation and reveal novel bioactive molecules with potential biomedical applications.

2. Results and Discussion

2.1. Venom Profile

Proteomic analyses revealed the presence of nine common protein families in the venoms of O. microlepidotus and O. scutellatus, including phospholipases A2 (PLA2), three-finger toxins (3FTxs), nerve growth factors (NGFs), prothrombin activators (PTAs), natriuretic peptides (NPs), cysteine-rich secretory proteins (CRISPs), BPTI/Kunitz protease inhibitors, and carboxypeptidases (Figure 1 and Figure 2). Among these, PLA2 and 3FTxs stand out as the major effector molecules, being directly responsible for most of the neurotoxic and systemic effects of taipan venoms. For this reason, these two toxin families are given priority in the discussion, with emphasis on their biochemical diversity and comparative roles between the species. In addition, the proteome of O. microlepidotus revealed the presence of a Waprin family protein, absent in O. scutellatus. Waprins are structurally related to WAP (Whey Acidic Proteins) and are known for their roles in innate immunity and immunomodulation, representing a noteworthy finding that broadens the functional landscape of taipan venoms [29,30].
The Waprin identified in the venom of O. microlepidotus designated Omwaprin-b (B5G6G7), is a protein that shares 94% sequence identity with a previously described protein from the same species, Omwaprin-a (P83952). This protein has demonstrated antimicrobial activity through membrane disruption, without exhibiting toxicity in mice or hemolytic activity, indicating both high specificity and potent antimicrobial efficacy [31]. Furthermore, two synthetic peptides derived from Omwaprin—OMW1 and OMW2—showed even greater antimicrobial potential, effectively inhibiting Candida albicans biofilmformation and inducing complete lysis of Escherichia coli and Staphylococcus aureus, further highlighting the strong bioactive potential of this toxin [32].
The structural analysis of Omwaprin-b (B5G6G7) identified a single binding pocket (Figure 3) with distinct physicochemical properties. The pocket displays a moderate drugability score (0.49) and a relatively small volume (103 Å3), suggesting a selective interaction site for small molecules or lipid head groups. Its strongly hydrophilic character, reflected by high polarity (11.0) and negative hydrophobicity (−2.2), indicates a preference for polar or charged targets, such as phospholipid head groups or peptidoglycan components in bacterial membranes. Moreover, the high solvent-accessible surface area (1262 Å2) combined with a balanced polar/apolar ratio (0.91) suggests broad accessibility, which may favor initial recognition and anchoring to bacterial membranes.
These structural features are consistent with the proposed mechanism of action of cysteine-rich antimicrobial peptides, in which pocket-mediated recognition precedes membrane disruption. In the case of Omwaprin-b, the Red Pocket may function as a selective anchoring site that facilitates interaction with bacterial membrane components, ultimately leading to destabilization of bilayer integrity and cell death. This aligns with established models of antimicrobial peptide function that emphasize selective binding to bacterial versus mammalian membranes. However, since these insights are derived from computational prediction, further experimental validation is necessary to confirm the specific molecular partners and to establish the functional contribution of this pocket to Omwaprin-b’s antimicrobial activity.
In addition to the Waprin family, two proteins (A0A670YUG0; A0A2I4HXH5) belonging to the 5′-nucleotidase family were also identified in the venom of O. microlepidotus. The proteins share high sequence identity (96%). Although the role of these enzymes in the snake venoms is not fully understood, studies suggest that their primary function is the generation of purines, which may contribute to central nervous system depression. Additionally, they have been implicated in hemostatic modulation through the inhibition of platelet aggregation [33].
Table 1 (O. microlepidotus) and Table 2 (O. scutellatus) summarize the proteins identified in the proteomic analysis.
To confirm the presence of the proteins identified in the proteomic analysis, the crude venom of both snake species was analyzed by MALDI-TOF mass spectrometry. As shown in Figure 4, the mass profiles of Oxyuranus venoms are comparable, displaying a range from 3000 m/z to 14,000 m/z. Most of the proteins identified in the venoms (Table 1 and Table 2) present theoretical masses within this range, supporting a correlation between the proteomic identifications and the experimentally observed mass spectra.

2.2. Phospholipases A2 (PLA2)

Both species exhibit a wide diversity of PLA2, as shown in Table 1 and Table 2. PLA2 are multifunctional enzymes present in the venoms of several snake species, primarily acting through the hydrolysis of membrane phospholipids. This enzymatic activity disrupts cellular membranes, inducing synaptic blockade through the depletion of synaptic vesicles, either by reducing endocytosis or increasing calcium permeability, which leads inhibitions of excitatory potential [13,14,15,16]—to myotoxicity, by promoting the hydrolysis of muscle fiber membranes [17].
Despite their high toxicity, PLA2 exhibit promising properties for the development of molecules with therapeutic potential. One study demonstrated that PLA2 found in the venom of Vipera berus berus display antimicrobial activity against Gram-positive bacteria, inhibiting their growth even when the catalytic site of the PLA2 is blocked, indicating that this effect is independent of its enzymatic properties [34]. Another study revealed antimalarial effects of PLA2 present in the venom of Crotalus adamanteus, inhibiting the attachment of the ookinete to the intestinal wall, also through non-enzymatic mechanisms [35]. Additionally, antitumor effects were observed in both in vitro and in vivo models using PLA2 isolated from Bothrops jararacussu, resulting in the inhibition of tumor cell proliferation [36].
Both studies species presented Taipoxin (P00614; P0CG57; P00615; P00616) and Paradoxin (Q45Z46) in their venoms—two isoforms belonging to the PLA2 class—which are considered the main toxins responsible for the effects observed during envenomation by these snakes [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. Taipoxin and Paradoxin are PLA2 of approximately 46 kDa, composed of a complex formed by three subunits: the alpha subunit, responsible for the neurotoxic action; and the beta and gamma subunits, which, although not directly active, enhance the neurotoxicity of the alpha subunit [37,38,39]. Although the alpha subunit of paradoxin was not identified in any of the venoms analyzed, two homologous proteins (A6MFM9; Q45Z48) were detected in the venom of O. scutellatus, with their sequence alignments presented in Figure 5. The gamma subunit of this toxin has not yet been sequenced.
Despite high sequence homology, A6MFM9 exhibits key residue substitutions relative to the Paradoxin-like alpha chain, including acidic-to-basic (E81K, D111R, E125R) and neutral-to-basic (S43R, Q73K, P131R, A143K) changes in conserved regions. These modifications increase local positive charge and raise the predicted isoelectric point (A6MFM9: pI = 8.90 vs. Paradoxin-like alpha chain: pI = 8.18), potentially affecting electrostatic interactions, structural stability, and functional properties. In contrast, Q45Z48 shows fewer substitutions, largely preserving the original charge distribution, with a predicted pI essentially identical to the reference, suggesting minimal impact on its physichochemical or functional characteristics. Independently, according to previous studies, the alpha subunit of taipoxin exhibits high enzymatic activity when isolated, with no enhancement of its activity upon complexation with the other subunit. This suggests that its enzymatic function is not directly dependent on the trimeric structure of the toxin [38]. Investigations involving paradoxin have shown that this phospholipase exerts a potent presynaptic neuromuscular blocking effect, potentially through the inhibition of potassium channels at nerve terminals, thereby suppressing neurotransmission [40].
The neurotoxic effect of the alpha subunit occurs through the alteration of the lipid composition of the axon terminal, promoting the dissociation of the Synaptophysin 1 (Syp1)-VAMP2 complex at nerve terminals. This dissociation allows Syp1 and VAMP2 to induce the formation and activation of the SNARE complex, which is essential for the docking of synaptic vesicles to the neuronal membrane, resulting in excessive neurotransmitter release and subsequent depletion [16,41,42,43,44]. In addition to their neurotoxic effects, taipoxin and paradoxin also exert myotoxic effects by promoting the degradation of the lipid layer of cell membranes [17].
In addition to these toxins, other PLA2 were identified in the venoms of both species, OS1 (Q4VRI5), present in both species, and OS2 (Q45Z47), identified in the venom of O. scutellatus, were characterized by Lambeau et al. (1990) [44]. According to the authors, both toxins bind to PLA2 receptors on muscle cell membranes with higher affinity than on neuronal cells. Despite targeting similar sites, only OS2 exhibited neurotoxic effects in in vivo models [45]. The action of OS2 involves the hydrolysis of phosphoglycerides present in the cell membrane in the presence of Ca2+, leading to tissue damage. Additionally, it can inhibit acetylcholine release at synapses, functioning as a beta-neurotoxin [21]. Other proteins identified in the venoms show homology to both OS1 (Figure 6) and OS2 (Figure 7).
Among OS1 homologs, Q45Z45 and Q45Z50 display residue substitutions that modulate their electrostatic profiles. Q45Z45 shows minor changes (N31D, D51H, H73Q) with a slight pI increase (4.94 vs. 4.79), potentially affecting local charge distribution and stability. In contrast, Q45Z50 carries multiple substitutions (T43R, R44Q, T58K, A51D, D51N), rendering it more negatively charged with a lower pI (4.56), which may influence electrostatic interactions, conformational stability, and functional properties. Q45Z51, however, closely resembles the reference (pI 4.80), suggesting minimal impact.
OS2 homologs exhibit marked residue substitutions that shift their predicted isoelectric points. Q4VRI7 (pI = 7.62) shows extensive changes, including neutral-to-basic (G41R, W137R), acidic-to-basic (D48H), basic-to-neutral (K58P, R61S, R87G, K102T, R114G, K134P, K135P), neutral-to-acidic (G80D, Q113E, A143E), and acidic-to-neutral (E77Q, E83V) substitutions, collectively increasing negative charge compared to OS2 (pI = 8.18). Q45Z49 (pI = 7.57) also harbors key substitutions—basic-to-acidic (R37E), neutral-to-basic (S43R), basic-to-neutral (R44Q, R61C, K58T), and acidic-to-neutral (D51N)—further lowering its pI. In contrast, Q4VRI4 (pI = 7.87) and Q45Z41 (pI = 8.06) share changes such as D48H and R61S, although Q4VRI4 uniquely presents a nonpolar-to-acidic substitution (A143E), rendering Q45Z41 more similar to OS2 in its electrostatic profile.
In the venom of O. microlepidotus, the PLA2 1 (P60043) was identified, originally characterized from the venom of Naja sagittifera [46]. It displays a heterodimeric structure and is calcium-dependent, with Ca2+ ions being essential for both its structural stability and catalytic activity on phospholipids. Similarly, PLA2 2 (P10116), identified in the venom of O. scutellatus, was initially isolated from Laticauda colubrina. This enzyme also exhibits Ca2+ dependent phospholipase activity, with a reported LD50 of 45 μg/kg [47].
Some PLA2s identified in this study have not yet been functionally described in the literature; however, they share significant homology with well-characterized proteins. An example is PLA2 S8-51 (Q9PUH0), a protein which exhibits high sequence similarity to notexin (P00608), as shown in the alignment presented in Figure 8. Notexin, originally isolated from the venom of Notechis scutatus scutatus, displays typical phospholipase activity, catalyzing the hydrolysis of phospholipids in muscle or neuronal cell membranes and inhibiting acetylcholine-mediated neurotransmission. Additionally, it has been shown to exert marked nephrotoxic effects in mice following subcutaneous administration, causing glomerular and tubular damage [48,49].
Protein Q9PUH0 exhibits structural features that distinguish it from notexin. A key difference is the greater prevalence of acidic residues, arising from multiple substitutions: basic-to-neutral (K16S43, K46Q73, K116T143), basic-to-acidic (K84E111, K115E142), neutral-to-acidic (G56E83, N74D101, N107D134, N111D138), neutral-to-basic (F98K125), and acidic-to-neutral (D50N77, D53G80, E73G100, E95I122). Collectively, these changes lower its predicted isoelectric point (Q9PUH0: pI = 5.08 vs. notexin: pI = 7.39). Such alterations may influence electrostatic intramolecular interactions, potentially impacting protein stability and conformation.
PLA2 accounted for approximately 47% of the proteins identified in O. microlepidotus (Figure 2), and about 66% of the proteins in O. scutellatus (Figure 2), indicating a higher relative abundance of this type of toxin in O. scutellatus venom.

2.3. Three-Fingers Toxins (3FTx)

Among the identified protein families, three-finger toxins (3FTxs) represent one of the most relevant groups in taipan venoms, given their abundance, structural versatility, and central role in neurotoxicity, the 3FTX were identified in both venoms (Table 1 and Table 2). 3FTx are peptides consisting of approximately 60 to 74 amino acid residues and are found in various snake families. Their structure is composed of three beta-sheet loops connected to a central core, forming a three-dimensional conformation that resembles three fingers, hence the name [50]. These toxins are highly potent, acting through interaction with acetylcholine receptors (AChRs), where they block the action of acetylcholine, leading to inhibition of neurotransmission at the neuromuscular junction and, consequently, to paralysis [51].
As observed with PLA2, a greater diversity of 3FTx was identified in the venom of O. microlepidotus, accounting approximately 33% of the identified proteins (Figure 2), compared to about 9% of the identified protein composition in O. scutellatus venom (Figure 2).
The toxin SNTX-1 (Q45Z11) found in the venom of O. scutellatus was described by Zamudio et al. [52]. According to the authors, this toxin exhibits a high inhibitory capacity on skeletal muscle AChRs, with an IC50 of 2.4 ± 0.4 nM. In contrast, it does not display the same affinity for brain AChRs, suggesting a postsynaptic site of action. The authors also described SNTX-2 (P0CB06), identified in the venom of both snake species. This 3FTx exhibits a mode of action similar to that of SNTX-1. Although SNTX-1 itself was not identified in the venom of O. microlepidotus, a homologous protein, named 3FTx-Oxy4 (A7X4S0) was detected. The sequence alignment is shown in Figure 9.
Three proteins identified in the venom of O. microlepidotus (A7X4R0; A8HDK8; A7X4Q3) and one protein identified in the venom of O. scutellatus (A8HDK9) show sequence homology to a well-characterized 3FTx, Elapitoxin-Oh3a (Q53B58). The alignment of these sequences is presented in Figure 10. This toxin was shown to induce blockade of nerve stimulation in the biventer cervicis muscle of chickens when challenged with endogenous acetylcholine and carbachol (CCh), both of which activate muscarinic and nicotinic receptors [53]. The authors also suggested a pseudo-irreversible antagonistic effect of this toxin based on a concentration-dependent, non-parallel rightward shift in the cumulative concentration-response to CCh, accompanied by a reduction in the maximal response in unstimulated chick muscle. However, this effect was not observed upon stimulation with KCl, further supporting a postsynaptic site of action for this toxin.
3FTx possess particularly relevant characteristics for studies targeting molecular mechanisms related to pain modulation. A series of 3FTxs with inhibitory action on acid-sensing ion channels (ASICs) has been characterized from the venom of the snake Dendroaspis polylepis, resulting in analgesic effects comparable to those of morphine [54]. Interestingly, some proteins identified in the venom of O. microlepidotus show a degree of sequence homology with one of the characterized 3FTx, mambalgin-1 (P0DKR6). The alignment of these sequences is presented in Figure 11.
ASICs are expressed in both the central and peripheral nervous systems (especially in nociceptive neurons) and play a key role in signaling and propagation of pain [55]. For this reason, the inhibition of these channels by 3FTx is directly associated with the induction of analgesia.
Recent studies have also revealed that ASICs are involved in processes within the central nervous system related to the release of neurotransmitters such as GABA and glutamate, and are implicated in pathophysiological mechanisms associated with neurological disorders such as epilepsy and Alzheimer’s disease [56,57]. These findings make 3FTxs promising targets for therapeutic investigations in neuroscience.

2.4. Other Proteins

In addition to the dominant toxin families, several other protein groups were identified in the venoms of O. microlepidotus and O. scutellatus (Table 1 and Table 2). Nerve growth factors (NGFs) accounted for ~1.45% and ~4.10% of proteins, respectively (Figure 2). Despite limited characterization of the sequences detected (Q3HXZ0; Q3I5F4), they show homology with NGF (Supplementary Figure S1) from Macrovipera lebetinus (P25428), previously reported to stimulate neurite outgrowth in PC12 cells [55,58,59,60,61,62,63]. Such findings reinforce the widespread presence of NGFs in snake venoms and their potential role beyond neuronal regulation, including tissue repair and neuroinflammatory processes. Prothrombin activators (PTAs) were also detected (~0.82% in O. microlepidotus and ~1.98% in O. scutellatus), with Oscutarin-C (Q58L96; Q58L91) identified in O. scutellatus as a potent procoagulant toxin, and the homolog Omicarin-C (Q58L95) present in O. microlepidotus (Supplementary Figure S2) [22,64,65,66,67,68,69].
Natriuretic peptides (NPs) constituted one of the most abundant protein classes among this group, reaching ~14.57% in O. microlepidotus and ~7.41% in O. scutellatus. Functional differences were observed, as TNP-b (P83228) from O. scutellatus exhibited reduced vasorelaxant activity and failed to activate the GC-A receptor, while homologs of TNP-c (Q3SAF8; Q3SAX8) (Supplementary Figure S3) identified in both species displayed potent vasodilatory effects [70,71,72,73,74,75,76]. These peptides resemble mammalian NPs in structure and activity, suggesting their involvement in prey immobilization via hypotension and highlighting their potential as templates for cardiovascular drug discovery. CRISPs were also identified, in smaller proportions (~0.58% and ~2.34%), including homologs such as pseudecin (Supplementary Figure S4), known to inhibit cyclic nucleotide-gated channels but with limited direct toxicity [77,78,79,80,81,82,83,84]. Notably, CRISPs have been associated with anti-angiogenic and antiparasitic activities in other species, expanding their relevance beyond envenomation.
Kunitz-type inhibitors added further diversity, with taicatoxin (B7S4N9) present in both venoms (~0.37% in O. microlepidotus and ~5.69% in O. scutellatus), acting as a heterotrimeric complex that blocks cardiac CaV channels [18,19,85,86,87,88,89,90,91,92]. In addition to classical protease inhibition, Kunitz toxins have been reported to modulate ion channels and display pharmacological properties, including AVP antagonism, anti-angiogenic, and anticoagulant activities [93,94,95,96]. Finally, carboxypeptidases (~0.74% and ~2.46%) were identified in both venoms (Figure 2). Although scarcely studied in snakes, these enzymes are known to cleave peptides at the carboxy-terminal end, participate in angiotensin regulation, coagulation, and inflammatory pathways [97,98]. Taken together, these protein families highlight the functional complexity of taipan venoms, extending their biological impact beyond neurotoxicity and supporting their potential as valuable models for biomedical applications.

3. Conclusions

Both Oxyuranus venoms exhibit a shared proteomic framework dominated by PLA2s and 3FTxs, yet a clear divergence in toxin repertoire highlights distinct functional strategies. While O. scutellatus venom appears predominantly PLA2-driven, reinforcing its role in presynaptic neurotoxicity and myotoxicity, O. microlepidotus displays an expanded diversity of 3FTxs coupled with the exclusive presence of 5′-nucleotidases and Waprin, indicating a broader range of neurotoxic and cardiocirculatory mechanisms. These compositional differences suggest evolutionary pressures that may underlie the greater lethality historically attributed to O. microlepidotus, potentially reflecting ecological adaptation through diversification of effector molecules. The identification of Waprin, alongside several uncharacterized proteins, not only broadens the functional scope of taipan venoms but also emphasizes their unexplored pharmacological potential, positioning them as valuable resources for future studies on toxin evolution, molecular mechanisms of envenomation, and the discovery of novel therapeutic leads.

4. Materials and Methods

4.1. Venom Fractioning

The lyophilized venoms of O. microlepidotus and O. scutellatus (3 mg each), provided by Venom Supplies (Tanunda, SA) were resuspended in 0.1% Trifluoroacetic Acid (TFA) and centrifuged (10,000× g) for 10 min, at 4 °C. The supernatant was then fractionated by reversed-phase high-performance liquid chromatography (RP-HPLC) in a Shimadzu Prominence binary system (Shimadzu, Kyoto, Japan), coupled to a C18 analytical column (250 mm × 4.6 mm, 5 m). UV detection was performed (SPDM 20A, Shimadzu, λ = 214 nm) and separation was achieved by a linear gradient of 20–100% solvent B (90% acetonitrile, containing 0.1% TFA) over A (0.1% TFA) for 50 min at a constant flow of 1mL·min−1. The use of this strategy aimed to enhance the resolution for fractionation, and later proteomic analysis, thereby enabling more precise identification and characterization of the venom constituents.

4.2. Fractions Characterization

4.2.1. Protein Digestion

The collected fractions (50 μL aliquots) were digested with trypsin (Sigma-Aldrich, St. Louis, MO, USA) following a standardized protocol. Initially, samples were buffed in 50 mM ammonium bicarbonate diluted in water and reduced with 5 μL of 100 mM dithiothreitol (DTT) at 60 °C for 30 min. Alkylation was performed using 5 μL of 100 mM iodoacetamide (IAA) in the dark for 45 min. Subsequently, enzymatic digestion was carried out with 240 ng of sequencing-grade trypsin at 30 °C for 16 h. Trypsin activity was quenched by the addition of 5 μL of 10% TFA, and the resulting peptide mixtures were stored at −20 °C until LC-MS/MS analysis.

4.2.2. Analysis by LC-ESI-IT-TOF/MS

The samples then were analyzed with liquid chromatography mass spectrometry in an ESI-IT-TOF instrument coupled to a UPLC 20A Prominence (Shimadzu, Kyoto, Japan). Samples (50 μL aliquots) were loaded into a C18 column (Kinetex C18, 5 μm; 50 mm × 2.1 mm) and fractionated by a binary gradient employing as solvents (A) water:acetic acid (999:1) and (B) ACN:water:acetic acid (949:50:1). An elution gradient of 0–40% B was applied for 80 min at a constant flow of 0.2 mL·min−1 after initial isocratic elution for 5 min. The eluates were monitored using a Shimadzu SPD-M20A PDA detector before being injected into the mass spectrometer.
The interface was kept at 4.5 kV and 200 °C. The detector operated at 1.95 kV and the argon collision induced fragmentation was set at 55 ‘energy’ value. MS spectra were acquired in positive mode in the 350–1400 m/z range, and MS/MS spectra were collected in the 50–1950 m/z range.

4.2.3. Analysis by MALDI-TOF/MS

The venoms were also analyzed using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer (Axima Performance, Shimadzu, Kyoto, Japan). One microliter of each sample was co-crystallized with 1 μL of α-cyano-4-hydroxycinnamic acid matrix (Sigma-Aldrich, St. Louis, MO, USA) for the low m/z range (1000~10,000) and with 1 μL of 3,5-dimethoxy-4-hydroxycinnamic acid (Sigma-Aldrich, St. Louis, MO, USA) for the high m/z range (8000~20,000). The plate containing the samples was then dried at room temperature. The mass spectrum was obtained in linear positive mode.

4.2.4. Proteomic Data Processing and Data Analysis

Raw LCD Shimadzu datafiles were converted into mzML files using the LCMSolution tool and then loaded into Peaks Studio V7.0 (Bioinformatic Solutions Inc., Waterloo, ON, Canada). Data were processed according to the following parameters: MS and MS/MS error mass were 0.1 Da; methionine oxidation and carbamidomethylation as variable and fixed modification, respectively; trypsin as cleaving enzyme; maximum missed cleavages (3), maximum variable PTMs per peptide (3), and non-specific (1). Data were analyzed against the “Snakes” database, compiled in December/2024 by UNIPROT. Only peptides with a −10logP (20) and proteins with a −10logP (20), containing at least one unique peptide, were considered in the analyses. Protein alignment was performed by Clustal Omega (v. 1.2.4) (EMBL-EBI). The theoretical mass was calculated by subtracting the mass of the signal peptide using the PeptideMass software (https://web.expasy.org/peptide_mass/, accessed on 26 August 2025).

4.2.5. Quantitative Analysis of Venom Proteins

The quantitative analysis of venom proteins was performed based following the approach described by Beraldo-Neto (2023) [99]: Quantification was based on the area under the chromatographic peaks, as calculated using LCMSolution software (v 1.25), and used as a proxy for protein abundance. In cases where multiple proteins co-eluted within the same retention time (i.e., within the same fraction), the relative contribution of each protein to the total peak area was estimated by normalizing the number of unique peptides identified for each protein.

4.3. Computational Pocket Mapping

We used the Deep Origin platform (Balto module) to perform automated binding pocket detection and characterization on the B5G6G7 (Omwaprin-b) structure. First, the input PDB file was cleaned and preprocessed (e.g., removal of water molecules, addition of missing atoms, protonation at physiological pH) through the built-in protein preparation routines. Next, the platform’s pocket-finding algorithm was invoked to scan the protein surface for putative ligand-binding cavities. Deep Origin exposes a Pocket class within its pipeline (via deeporigin.drug_discovery.Pocket) that supports operations such as from_pdb_file, from_pocket_finder_results, and get_center, enabling extraction of pocket geometry and coordinate data. client-docs.deeporigin.io.
Once pockets were detected, the system computed a panel of pocket descriptors including volume, hydrophobicity, polarity, total solvent-accessible surface area (SASA), and drugability score. These metrics are drawn from internal scoring models that integrate physical and statistical features (e.g., topology, atom types, hydrophobic patches) to estimate drug-likeness. The pocket center coordinates were derived by averaging the atomic positions within the cavity (via the get_center() method). The default docking grid box size (24 Å) was applied around the pocket center for further docking and validation procedures. After annotation, the highest-scoring pocket (“Red Pocket”) was selected for downstream mechanistic interpretation and binding modeling.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxins17100488/s1, Figure S1: ClustalW alignment of NGF-homologous NGF identified in the venoms of O. microlepidotus: Q3HXZ0, and O. scutellatus: Q3HXZ0 and Q3I5F4. NGF is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge; Figure S2: ClustalW alignment of Oscutarin-C-homologous VPTA identified in the venom of O. microlepidotus: Q58L95. Oscutarin-C is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge. Figure S3: ClustalW alignment of TNP-c-homologous NP identified in the venom of O. microlepidotus: Q3SAF8 and Q3SAX8. TNP-c is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge. Figure S4: ClustalW alignment of Pseudecin-homologous CRISPs identified in the venoms of O. microlepidotus: Q3SB07, and O. scutellatus: Q3SB07 and Q8UW11. Pseudecin is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.

Author Contributions

Conceptualization, G.G.P. and E.B.-N.; writing—original draft preparation, G.G.P.; writing—review and editing, E.B.-N. and P.J.S.; supervision and funding acquisition, D.C.P. and E.B.-N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Butantan Foundation grant number 001/0708/000.590/2023 and 001/0708/000.126/2025 to DCP; FAPESP Grant 2024/10962-9 and 2022/11535-1; DCP is a National Council for Scientific and Technological Development (CNPq) fellow (305525/2023-9).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The proteomic data presented in this study are available on request from the corresponding author due to the confidentiality clauses reason.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Hardy, M.C.; Cochrane, J.; Allavena, R.E. Venomous and poisonous Australian animals of veterinary importance: A rich source of novel therapeutics. BioMed Res. Int. 2014, 2014, 671041. [Google Scholar] [CrossRef] [PubMed]
  2. Williams, D.; Wüster, W.; Fry, B.G. The good, the bad and the ugly: Australian snake taxonomists and a history of the taxonomy of Australia’s venomous snakes. Toxicon 2006, 48, 919–930. [Google Scholar] [CrossRef]
  3. Jackson, T.N.W.; Sunagar, K.; Undheim, E.A.B.; Koludarov, I.; Chan, A.H.C.; Sanders, K.; Ali, S.A.; Hendrikx, I.; Dunstan, N.; Fry, B.G. Venom down under: Dynamic evolution of Australian elapid snake toxins. Toxins 2013, 5, 2621–2655. [Google Scholar] [CrossRef]
  4. Kocholaty, W.F.; Ledford, E.B.; Daly, J.G.; Billings, T.A. Toxicity and some enzymatic properties and activities in the venoms of Crotalidae, Elapidae and Viperidae. Toxicon 1971, 9, 131–138. [Google Scholar] [CrossRef]
  5. Doughty, P.; Maryan, B.; Donnellan, S.C.; Hutchinson, M.N. A new species of taipan (Elapidae: Oxyuranus) from central Australia. Zootaxa 2007, 1422, 45–58. [Google Scholar] [CrossRef]
  6. Kornhauser, R.; Hart, A.J.; Reeve, S.; Smith, A.I.; Fry, B.G.; Hodgson, W.C. Variations in the pharmacological profile of post-synaptic neurotoxins isolated from the venoms of the Papuan (Oxyuranus scutellatus canni) and coastal (Oxyuranus scutellatus scutellatus) taipans. Neurotoxicology 2010, 31, 239–243. [Google Scholar] [CrossRef]
  7. Lalloo, D.G.; Trevett, A.J.; Korinhona, A.; Nwokolo, N.; Laurenson, I.F.; Paul, M.; Black, J.; Naraqi, S.; Mavo, B.; Saweri, A. Snakebites by the Papuan taipan (Oxyuranus scutellatus canni): Paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am. J. Trop. Med. Hyg. 1995, 52, 525–531. [Google Scholar] [CrossRef] [PubMed]
  8. Barber, C.M.; Madaras, F.; Turnbull, R.K.; Morley, T.; Dunstan, N.; Allen, L.; Kuchel, T.; Mirtschin, P.; Hodgson, W.C. Comparative studies of the venom of a new Taipan species, Oxyuranus temporalis, with other members of its genus. Toxins 2014, 6, 1979–1995. [Google Scholar] [CrossRef] [PubMed]
  9. Crachi, M.T.; Hammer, L.W.; Hodgson, W.C. The effects of antivenom on the in vitro neurotoxicity of venoms from the taipans Oxyuranus scutellatus, Oxyuranus microlepidotus and Oxyuranus scutellatus canni. Toxicon 1999, 37, 1771–1778. [Google Scholar] [CrossRef]
  10. Brennan, K.E.C.; Morley, T.; Hutchinson, M.; Donnellan, S. Redescription of the western desert taipan, Oxyuranus temporalis (Serpentes: Elapidae), with notes on its distribution, diet and genetic variation. Aust. J. Zool. 2011, 59, 227. [Google Scholar] [CrossRef]
  11. Johnston, C.I.; Ryan, N.M.; O’Leary, M.A.; Brown, S.G.A.; Isbister, G.K. Australian taipan (Oxyuranus spp.) envenoming: Clinical effects and potential benefits of early antivenom therapy—Australian Snakebite Project (ASP-25). Clin. Toxicol. 2017, 55, 115–122. [Google Scholar] [CrossRef] [PubMed]
  12. Williams, D.; Bal, B. Papuan Taipan (‘Oxyuranus scutellatus canni’) envenomation in rural Papua New Guinea. Ann. ACTM Int. J. Trop. Travel Med. 2003, 4, 6–9. [Google Scholar]
  13. Su, M.J.; Chang, C.C. Presynaptic effects of snake venom toxins which have phospholipase A2 activity (beta-bungarotoxin, taipoxin, crotoxin). Toxicon 1984, 22, 631–640. [Google Scholar] [CrossRef] [PubMed]
  14. Tzeng, M.C.; Yen, C.H.; Hseu, M.J.; Tseng, C.C.; Tsai, M.D.; Dupureur, C.M. Binding proteins on synaptic membranes for crotoxin and taipoxin, two phospholipases A2 with neurotoxicity. Toxicon 1995, 33, 451–457. [Google Scholar] [CrossRef] [PubMed]
  15. Fathi, B.; Harvey, A.L.; Rowan, E.G. The effect of temperature on the effects of the phospholipase A neurotoxins beta-bungarotoxin and taipoxin at the neuromuscular junction. Toxicon 2013, 70, 86–89. [Google Scholar] [CrossRef]
  16. Treppmann, P.; Brunk, I.; Afube, T.; Richter, K.; Ahnert-Hilger, G. Neurotoxic phospholipases directly affect synaptic vesicle function. J. Neurochem. 2011, 117, 757–764. [Google Scholar] [CrossRef]
  17. Harris, J.B.; Maltin, C.A. Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus. Br. J. Pharmacol. 1982, 76, 61–75. [Google Scholar] [CrossRef]
  18. Possani, L.D.; Martin, B.M.; Yatani, A.; Mochca-Morales, J.; Zamudio, F.Z.; Gurrola, G.B.; Brown, A.M. Isolation and physiological characterization of taicatoxin, a complex toxin with specific effects on calcium channels. Toxicon 1992, 30, 1343–1364. [Google Scholar] [CrossRef]
  19. Earl, S.T.H.; Richards, R.; Johnson, L.A.; Flight, S.; Anderson, S.; Liao, A.; de Jersey, J.; Masci, P.P.; Lavin, M.F. Identification and characterisation of Kunitz-type plasma kallikrein inhibitors unique to Oxyuranus sp. snake venoms. Biochimie 2012, 94, 365–373. [Google Scholar] [CrossRef]
  20. Su, M.C.; Lee, S.Y.; Tan, C.T.; Su, C.C.; Li, S.Y.; Lin, R.H.; Hung, C.C.; Lin, M.J. Taicatoxin inhibits the calcium-dependent slow motility of mammalian outer hair cells. Hear. Res. 2005, 203, 172–179. [Google Scholar] [CrossRef]
  21. Rouault, M.; Rash, L.D.; Escoubas, P.; Boilard, E.; Bollinger, J.; Lomonte, B.; Maurin, T.; Guillaume, C.; Canaan, S.; Deregnaucourt, C.; et al. Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: The N-terminal region is more important than enzymatic activity. Biochemistry 2006, 45, 5800–5816. [Google Scholar] [CrossRef]
  22. Herrera, M.; Fernández, J.; Vargas, M.; Villalta, M.; Segura, Á.; León, G.; Angulo, Y.; Paiva, O.; Matainaho, T.; Jensen, S.D.; et al. Comparative proteomic analysis of the venom of the taipan snake, Oxyuranus scutellatus, from Papua New Guinea and Australia: Role of neurotoxic and procoagulant effects in venom toxicity. J. Proteom. 2012, 75, 2128–2140. [Google Scholar] [CrossRef]
  23. St Pierre, L.; Fischer, H.; Adams, D.J.; Schenning, M.; Lavidis, N.; de Jersey, J.; Masci, P.P.; Lavin, M.F. Distinct activities of novel neurotoxins from Australian venomous snakes for nicotinic acetylcholine receptors. Cell. Mol. Life Sci. 2007, 64, 2829–2840. [Google Scholar] [CrossRef]
  24. Fry, B.G.; Wickramaratana, J.C.; Lemme, S.; Beuve, A.; Garbers, D.; Hodgson, W.C.; Alewood, P. Novel natriuretic peptides from the venom of the inland taipan (Oxyuranus microlepidotus): Isolation, chemical and biological characterization. Biochem. Biophys. Res. Commun. 2005, 327, 1011–1015. [Google Scholar] [CrossRef]
  25. Morrison, J.; Pearn, J.; Covacevich, J.; Tanner, C.; Coulter, A. Studies on the venom of Oxyuranus microlepidotus. J. Toxicol. Clin. Toxicol. 1983, 21, 373–385. [Google Scholar] [CrossRef]
  26. Broad, A.J.; Sutherland, S.K.; Coulter, A.R. The lethality in mice of dangerous Australian and other snake venom. Toxicon 1979, 17, 661–664. [Google Scholar] [CrossRef]
  27. Tasoulis, T.; Silva, A.; Veerati, P.C.; Baker, M.; Hodgson, W.C.; Dunstan, N.; Isbister, G.K. Intra-Specific Venom Variation in the Australian Coastal Taipan Oxyuranus scutellatus. Toxins 2020, 12, 485. [Google Scholar] [CrossRef] [PubMed]
  28. van Thiel, J.; Alonso, L.L.; Slagboom, J.; Dunstan, N.; Wouters, R.M.; Modahl, C.M.; Vonk, F.J.; Jackson, T.N.W.; Kool, J. Highly Evolvable: Investigating Interspecific and Intraspecific Venom Variation in Taipans (Oxyuranus spp.) and Brown Snakes (Pseudonaja spp.). Toxins 2023, 15, 74. [Google Scholar] [CrossRef] [PubMed]
  29. Torres, A.M.; Wong, H.Y.; Desai, M.; Moochhala, S.; Kuchel, P.W.; Kini, R.M. Identification of a novel family of proteins in snake venoms. J. Biol. Chem. 2003, 278, 40097–40104. [Google Scholar] [CrossRef]
  30. Wilkinson, T.S.; Roghanian, A.; Simpson, A.J.; Sallenave, J.M. WAP domain proteins as modulators of mucosal immunity. Biochem. Soc. Trans. 2011, 39, 1409–1415. [Google Scholar] [CrossRef] [PubMed]
  31. Nair, D.G.; Fry, B.G.; Alewood, P.; Kumar, P.P.; Kini, R.M. Antimicrobial activity of omwaprin, a new member of the Waprin family of snake venom proteins. Biochem. J. 2007, 402, 93–104. [Google Scholar] [CrossRef]
  32. Thankappan, B.; Angayarkanni, J. Biological characterization of omw1 and omw2: Antimicrobial peptides derived from omwaprin. 3 Biotech 2019, 9, 295. [Google Scholar] [CrossRef] [PubMed]
  33. Dhananjaya, B.L.; D’Souza, C.J.M. The pharmacological role of nucleotidases in snake venoms. Cell Biochem. Funct. 2010, 28, 171–177. [Google Scholar] [CrossRef]
  34. Samel, M.; Vija, H.; Kurvet, I.; Künnis-Beres, K.; Trummal, K.; Subbi, J.; Kahru, A.; Siigur, J. Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells. Toxins 2013, 5, 203–223. [Google Scholar] [CrossRef] [PubMed]
  35. Zieler, H.; Keister, D.B.; Dvorak, J.A.; Ribeiro, J.M. A snake venom phospholipase A2 blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface. J. Exp. Biol. 2001, 204, 4157–4167. [Google Scholar] [CrossRef] [PubMed]
  36. Gebrim, L.C.; Marcussi, S.; Menaldo, D.L.; de Menezes, C.S.R.; Nomizo, A.; Hamaguchi, A.; Silveira-Lacerda, E.P.; Homsi Brandeburgo, M.I.; Sampaio, S.V.; Soares, A.M.; et al. Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region. Biologicals 2009, 37, 222–229. [Google Scholar] [CrossRef] [PubMed]
  37. Fohlman, J.; Eaker, D.; Karlsoon, E.; Thesleff, S. Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the australian snake taipan (Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties. Eur. J. Biochem. 1976, 68, 457–469. [Google Scholar] [CrossRef]
  38. Cendron, L.; Mičetić, I.; Polverino de Laureto, P.; Paoli, M. Structural analysis of trimeric phospholipase A2 neurotoxin from the Australian taipan snake venom. FEBS J. 2012, 279, 3121–3135. [Google Scholar] [CrossRef]
  39. Harrison, J.A.; Aquilina, J.A. Insights into the subunit arrangement and diversity of paradoxin and taipoxin. Toxicon 2016, 112, 45–50. [Google Scholar] [CrossRef]
  40. Hodgson, W.C.; Dal Belo, C.A.; Rowan, E.G. The neuromuscular activity of paradoxin: A presynaptic neurotoxin from the venom of the inland taipan (Oxyuranus microlepidotus). Neuropharmacology 2007, 52, 1229–1236. [Google Scholar] [CrossRef]
  41. Apel, A.R.; Hoban, K.; Chuartzman, S.; Tonikian, R.; Sidhu, S.; Schuldiner, M.; Wendland, B.; Prosser, D. Syp1 regulates the clathrin-mediated and clathrin-independent endocytosis of multiple cargo proteins through a novel sorting motif. Mol. Biol. Cell 2017, 28, 2434–2448. [Google Scholar] [CrossRef]
  42. Oishi, Y.; Arakawa, T.; Tanimura, A.; Itakura, M.; Takahashi, M.; Tajima, Y.; Mizoguchi, I.; Takuma, T. Role of VAMP-2, VAMP-7, and VAMP-8 in constitutive exocytosis from HSY cells. Histochem. Cell Biol. 2006, 125, 273–281. [Google Scholar] [CrossRef] [PubMed]
  43. Bonanomi, D.; Pennuto, M.; Rigoni, M.; Rossetto, O.; Montecucco, C.; Valtorta, F. Taipoxin induces synaptic vesicle exocytosis and disrupts the interaction of synaptophysin I with VAMP2. Mol. Pharmacol. 2005, 67, 1901–1908. [Google Scholar] [CrossRef] [PubMed]
  44. Lambeau, G.; Schmid-Alliana, A.; Lazdunski, M.; Barhanin, J. Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle. J. Biol. Chem. 1990, 265, 9526–9532. [Google Scholar] [CrossRef]
  45. Kolko, M.; Bruhn, T.; Christensen, T.; Lazdunski, M.; Lambeau, G.; Bazan, N.G.; Diemer, N.H. Secretory phospholipase A2 potentiates glutamate-induced rat striatal neuronal cell death in vivo. Neurosci. Lett. 1999, 274, 167–170. [Google Scholar] [CrossRef]
  46. Jabeen, T.; Sharma, S.; Singh, N.; Singh, R.K.; Kaur, P.; Perbandt, M.; Betzel, C.; Srinivasan, A.; Singh, T.P. Crystal structure of a calcium-induced dimer of two isoforms of cobra phospholipase A2 at 1.6 Å resolution. Proteins 2005, 59, 856–863. [Google Scholar] [CrossRef]
  47. Takasaki, C.; Kimura, S.; Kokubun, Y.; Tamiya, N. Isolation, properties and amino acid sequences of a phospholipase A2 and its homologue without activity from the venom of a sea snake, Laticauda colubrina, from the Solomon Islands. Biochem. J. 1988, 253, 869–875. [Google Scholar] [CrossRef] [PubMed]
  48. Halpert, J.; Eaker, D.; Karlsson, E. The role of phospholipase activity in the action of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake). FEBS Lett. 1976, 61, 72–76. [Google Scholar] [CrossRef]
  49. Zimmerman, S.E.; Yong, L.C. Nephrotoxicity of notexin in experimental mice. Exp. Toxicol. Pathol. 1995, 47, 149–155. [Google Scholar] [CrossRef]
  50. Kini, R.M.; Doley, R. Structure, function and evolution of three-finger toxins: Mini proteins with multiple targets. Toxicon 2010, 56, 855–867. [Google Scholar] [CrossRef]
  51. Hiremath, K.; Dodakallanavar, J.; Sampat, G.H.; Patil, V.S.; Harish, D.R.; Chavan, R.; Hegde, H.V.; Roy, S. Three finger toxins of elapids: Structure, function, clinical applications and its inhibitors. Mol. Divers. 2024, 28, 3409–3426. [Google Scholar] [CrossRef] [PubMed]
  52. Zamudio, F.; Wolf, K.M.; Martin, B.M.; Possani, L.D.; Chiappinelli, V.A. Two novel alpha-neurotoxins isolated from the taipan snake, Oxyuranus scutellatus, exhibit reduced affinity for nicotinic acetylcholine receptors in brain and skeletal muscle. Biochemistry 1996, 35, 7910–7916. [Google Scholar] [CrossRef]
  53. Huynh, T.M.; Silva, A.; Isbister, G.K.; Hodgson, W.C. Isolation and pharmacological characterization of α-elapitoxin-Oh3a, a long-chain post-synaptic neurotoxin from King Cobra (Ophiophagus hannah) venom. Front. Pharmacol. 2022, 13, 815069. [Google Scholar] [CrossRef]
  54. Diochot, S.; Baron, A.; Salinas, M.; Douguet, D.; Scarzello, S.; Dabert-Gay, A.S.; Debayle, D.; Friend, V.; Alloui, A.; Lazdunski, M.; et al. Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature 2012, 490, 552–555. [Google Scholar] [CrossRef]
  55. Trummal, K.; Tõnismägi, K.; Paalme, V.; Järvekülg, L.; Siigur, J.; Siigur, E. Molecular diversity of snake venom nerve growth factors. Toxicon 2011, 58, 363–368. [Google Scholar] [CrossRef] [PubMed]
  56. Kweon, H.J.; Suh, B.C. Acid-sensing ion channels (ASICs): Therapeutic targets for neurological diseases and their regulation. BMB Rep. 2013, 46, 295–304. [Google Scholar] [CrossRef]
  57. Storozhuk, M.; Cherninskyi, A.; Maximyuk, O.; Isaev, D.; Krishtal, O. Acid-sensing ion channels: Focus on physiological and some pathological roles in the brain. Curr. Neuropharmacol. 2021, 19, 1570–1589. [Google Scholar]
  58. Levi-Montalcini, R.; Angeletti, P.U. Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev. Biol. 1963, 7, 653–659. [Google Scholar] [CrossRef]
  59. Paalme, V.; Trummal, K.; Samel, M.; Tõnismägi, K.; Järvekülg, L.; Vija, H.; Subbi, J.; Siigur, J.; Siigur, E. Nerve growth factor from Vipera lebetina venom. Toxicon 2009, 54, 329–336. [Google Scholar] [CrossRef]
  60. Fry, B.G. From genome to “venome”: Molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins. Genome Res. 2005, 15, 403–420. [Google Scholar] [CrossRef] [PubMed]
  61. Sunagar, K.; Fry, B.G.; Jackson, T.N.W.; Casewell, N.R.; Undheim, E.A.B.; Vidal, N.; Ali, S.A.; King, G.F.; Vasudevan, K.; Vasconcelos, V.; et al. Molecular evolution of vertebrate neurotrophins: Co-option of the highly conserved nerve growth factor gene into the advanced snake venom arsenal. PLoS ONE 2013, 8, e81827. [Google Scholar] [CrossRef]
  62. Rocco, M.L.; Soligo, M.; Manni, L.; Aloe, L. Nerve growth factor: Early studies and recent clinical trials. Curr. Neuropharmacol. 2018, 16, 1455–1465. [Google Scholar] [CrossRef]
  63. Capsoni, S.; Cattaneo, A. On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease. Cell. Mol. Neurobiol. 2006, 26, 619–633. [Google Scholar] [CrossRef] [PubMed]
  64. Rosing, J.; Tans, G. Structural and functional properties of snake venom prothrombin activators. Toxicon 1992, 30, 1515–1527. [Google Scholar] [CrossRef] [PubMed]
  65. Rosing, J.; Tans, G. Snake venom prothrombin activators—The history. In Toxins and Hemostasis; Springer: Dordrecht, The Netherlands, 2010; pp. 485–499. [Google Scholar]
  66. Kini, R.M. The intriguing world of prothrombin activators from snake venom. Toxicon 2005, 45, 1133–1145. [Google Scholar] [CrossRef]
  67. St Pierre, L.; Masci, P.P.; Filippovich, I.; Sorokina, N.; Marsh, N.; Miller, D.J.; Lavin, M.F. Comparative analysis of prothrombin activators from the venom of Australian elapids. Mol. Biol. Evol. 2005, 22, 1853–1864. [Google Scholar] [CrossRef] [PubMed]
  68. Tacon, C.L.; Munas, A.; Little, M. Case report: Rotational thromboelastometry in taipan envenomation. Am. J. Trop. Med. Hyg. 2021, 106, 746–749. [Google Scholar] [CrossRef]
  69. Waheed, H.; Moin, S.F.; Choudhary, M.I. Snake venom: From deadly toxins to life-saving therapeutics. Curr. Med. Chem. 2017, 24, 1874–1891. [Google Scholar] [CrossRef]
  70. Daniels, L.B.; Maisel, A.S. Natriuretic peptides. J. Am. Coll. Cardiol. 2007, 50, 2357–2368. [Google Scholar] [CrossRef]
  71. Nakao, K.; Ogawa, Y.; Suga, S.I.; Imura, H. Molecular biology and biochemistry of the natriuretic peptide system. In Molecular Reviews in Cardiovascular Medicine; Springer: Dordrecht, The Netherlands, 1996; pp. 74–82. [Google Scholar]
  72. Fry, B.G.; Vidal, N.; Norman, J.A.; Vonk, F.J.; Scheib, H.; Ramjan, S.F.R.; Kuruppu, S.; Fung, K.; Hedges, S.B.; Richardson, M.K.; et al. Early evolution of the venom system in lizards and snakes. Nature 2006, 439, 584–588. [Google Scholar] [CrossRef]
  73. Vink, S.; Jin, A.H.; Poth, K.J.; Head, G.A.; Alewood, P.F. Natriuretic peptide drug leads from snake venom. Toxicon 2012, 59, 434–445. [Google Scholar] [CrossRef] [PubMed]
  74. Zhang, Y.; Wu, J.; Yu, G.; Chen, Z.; Zhou, X.; Zhu, S.; Li, R.; Zhang, Y.; Lu, Q. A novel natriuretic peptide from the cobra venom. Toxicon 2011, 57, 134–140. [Google Scholar] [CrossRef]
  75. Chen, H.H.; Burnett Jr, J.C. Clinical application of the natriuretic peptides in heart failure. Eur. Heart J. Suppl. 2006, 8, E18–E25. [Google Scholar] [CrossRef]
  76. Ang, W.F.; Koh, C.Y.; Kini, R.M. From snake venoms to therapeutics: A focus on natriuretic peptides. Pharmaceuticals 2022, 15, 1153. [Google Scholar] [CrossRef]
  77. Krätzschmar, J.; Haendler, B.; Eberspaecher, U.; Roosterman, D.; Donner, P.; Schleuning, W.D. The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur. J. Biochem. 1996, 236, 827–836. [Google Scholar] [CrossRef]
  78. Cohen, D.J.; Maldera, J.A.; Weigel Muñoz, M.; Ernesto, J.I.; Vasen, G.; Cuasnicu, P.S. Cysteine-Rich Secretory Proteins (CRISP) and their role in mammalian fertilization. Biol. Res. 2011, 44, 135–138. [Google Scholar] [CrossRef]
  79. Yamazaki, Y.; Hyodo, F.; Morita, T. Wide distribution of cysteine-rich secretory proteins in snake venoms: Isolation and cloning of novel snake venom cysteine-rich secretory proteins. Arch. Biochem. Biophys. 2003, 412, 133–141. [Google Scholar] [CrossRef] [PubMed]
  80. Tadokoro, T.; Modahl, C.M.; Maenaka, K.; Aoki-Shioi, N. Cysteine-rich secretory proteins (CRISPs) from venomous snakes: An overview of the functional diversity in a large and underappreciated superfamily. Toxins 2020, 12, 175. [Google Scholar] [CrossRef] [PubMed]
  81. Snutch, T.P. Voltage-Gated Calcium Channels. In Encyclopedia of Neuroscience; Elsevier: Amsterdam, The Netherlands, 2009; pp. 427–441. [Google Scholar]
  82. Yamazaki, Y.; Brown, R.L.; Morita, T. Purification and cloning of toxins from elapid venoms that target cyclic nucleotide-gated ion channels. Biochemistry 2002, 41, 11331–11337. [Google Scholar] [CrossRef]
  83. Lecht, S.; Chiaverelli, R.A.; Gerstenhaber, J.; Calvete, J.J.; Lazarovici, P.; Casewell, N.R.; Harrison, R.; Lelkes, P.I.; Marcinkiewicz, C. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki. Biochim. Biophys. Acta 2015, 1850, 1169–1179. [Google Scholar] [CrossRef]
  84. Adade, C.M.; Carvalho, A.L.O.; Tomaz, M.A.; Costa, T.F.R.; Godinho, J.L.; Melo, P.A.; Lima, A.P.C.A.; Rodrigues, J.C.F.; Zingali, R.B.; Souto-Padrón, T. Crovirin, a snake venom cysteine-rich secretory protein (CRISP) with promising activity against Trypanosomes and Leishmania. PLoS Negl. Trop. Dis. 2014, 8, e3252. [Google Scholar] [CrossRef]
  85. Zupunski, V.; Kordis, D.; Gubensek, F. Adaptive evolution in the snake venom Kunitz/BPTI protein family. FEBS Lett. 2003, 547, 131–136. [Google Scholar] [CrossRef]
  86. Ranasinghe, S.; McManus, D.P. Structure and function of invertebrate Kunitz serine protease inhibitors. Dev. Comp. Immunol. 2013, 39, 219–227. [Google Scholar] [CrossRef]
  87. Kunitz, M.; Northrop, J.H. Isolation from beef pancreas of crystalline trypsinogen, trypsin, a trypsin inhibitor, and an inhibitor trypsin compound. J. Gen. Physiol. 1936, 19, 991–1007. [Google Scholar] [CrossRef]
  88. Huber, R.; Kukla, D.; Rhlmann, A.; Epp, O.; Formanek, H. The basic trypsin inhibitor of bovine pancreas. Sci. Nat. 1970, 57, 389–392. [Google Scholar] [CrossRef]
  89. Millers, E.K.I.; Trabi, M.; Masci, P.P.; Lavin, M.F.; de Jersey, J.; Guddat, L.W. Crystal structure of textilinin-1, a Kunitz-type serine protease inhibitor from the venom of the Australian common brown snake (Pseudonaja textilis). FEBS J. 2009, 276, 3163–3175. [Google Scholar] [CrossRef] [PubMed]
  90. Chen, C.; Hsu, C.H.; Su, N.Y.; Lin, Y.C.; Chiou, S.H.; Wu, S.H. Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus. J. Biol. Chem. 2001, 276, 45079–45087. [Google Scholar] [CrossRef] [PubMed]
  91. Harvey, A.L. Twenty years of dendrotoxins. Toxicon 2001, 39, 15–26. [Google Scholar] [CrossRef]
  92. Schweitz, H.; Heurteaux, C.; Bois, P.; Moinier, D.; Romey, G.; Lazdunski, M. Calcicludine, a venom peptide of the Kunitz-type protease inhibitor family, is a potent blocker of high-threshold Ca2+ channels with a high affinity for L-type channels in cerebellar granule neurons. Proc. Natl. Acad. Sci. USA 1994, 91, 878–882. [Google Scholar] [CrossRef] [PubMed]
  93. Droctové, L.; Ciolek, J.; Mendre, C.; Chorfa, A.; Huerta, P.; Carvalho, C.; Gouin, C.; Lancien, M.; Stanajic-Petrovic, G.; Braco, L.; et al. A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor. Br. J. Pharmacol. 2022, 179, 3470–3481. [Google Scholar] [CrossRef]
  94. Morjen, M.; Honoré, S.; Bazaa, A.; Abdelkafi-Koubaa, Z.; Ellafi, A.; Mabrouk, K.; Kovacic, H.; El Ayeb, M.; Marrakchi, N.; Luis, J. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis. Microvasc. Res. 2014, 95, 149–156. [Google Scholar] [CrossRef]
  95. Morjen, M.; Kallech-Ziri, O.; Bazaa, A.; Othman, H.; Mabrouk, K.; Zouari-Kessentini, R.; Sanz, L.; Calvete, J.J.; Srairi-Abid, N.; El Ayeb, M.; et al. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells. Matrix Biol. 2013, 32, 52–62. [Google Scholar] [CrossRef]
  96. Mukherjee, A.K.; Mackessy, S.P. Pharmacological properties and pathophysiological significance of a Kunitz-type protease inhibitor (Rusvikunin-II) and its protein complex (Rusvikunin complex) purified from Daboia russelii russelii venom. Toxicon 2014, 89, 55–66. [Google Scholar] [CrossRef]
  97. Jeong, J.K.; Diano, S. Prolyl carboxypeptidase and its inhibitors in metabolism. Trends Endocrinol. Metab. 2013, 24, 61–67. [Google Scholar] [CrossRef] [PubMed]
  98. Graham, T.H. Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: A patent review. Expert. Opin. Ther. Pat. 2017, 27, 1077–1088. [Google Scholar] [CrossRef] [PubMed]
  99. Beraldo-Neto, E.; Vigerelli, H.; Coelho, G.R.; da Silva, D.L.; Nencioni, A.L.A.; Pimenta, D.C. Unraveling and profiling Tityus bahiensis venom: Biochemical analyses of the major toxins. J. Proteom. 2023, 274, 104824. [Google Scholar] [CrossRef] [PubMed]
Toxins 17 00488 g001
Figure 1. Chromatographic profile of O. microlepidotus and O. scutellatus, showing the compounds identified within the respective fractions.
Figure 1. Chromatographic profile of O. microlepidotus and O. scutellatus, showing the compounds identified within the respective fractions.
Toxins 17 00488 g001
Toxins 17 00488 g002
Figure 2. Comparative quantitative analysis of protein families identified in O. scutellatus and O. microlepidotus.
Figure 2. Comparative quantitative analysis of protein families identified in O. scutellatus and O. microlepidotus.
Toxins 17 00488 g002
Toxins 17 00488 g003
Figure 3. Three-dimensional structure of Omwaprin-b (B5G6G7) highlighting the identified Red Pocket. The protein backbone is represented as a ribbon diagram, while the Red Pocket is shown as a surface cavity centered at coordinates [−8.2, 7.8, 1.9]. Pocket features include a relatively small volume (103 Å3), high polarity, and moderate drugability score (0.49), consistent with selective recognition of polar membrane components and a potential role in antimicrobial activity.
Figure 3. Three-dimensional structure of Omwaprin-b (B5G6G7) highlighting the identified Red Pocket. The protein backbone is represented as a ribbon diagram, while the Red Pocket is shown as a surface cavity centered at coordinates [−8.2, 7.8, 1.9]. Pocket features include a relatively small volume (103 Å3), high polarity, and moderate drugability score (0.49), consistent with selective recognition of polar membrane components and a potential role in antimicrobial activity.
Toxins 17 00488 g003
Toxins 17 00488 g004
Figure 4. MALDI-TOF spectra from the venoms of Oxyuranus scutellatus (blue) and Oxyuranus microlepidotus (red).
Figure 4. MALDI-TOF spectra from the venoms of Oxyuranus scutellatus (blue) and Oxyuranus microlepidotus (red).
Toxins 17 00488 g004
Toxins 17 00488 g005
Figure 5. ClustalW alignment of Paradoxin alpha chain-homologous PLA2 identified in the venom of O. scutellatus: A6MFM9 and Q45Z48. Paradoxin is highlighted in gray. “*” --> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 5. ClustalW alignment of Paradoxin alpha chain-homologous PLA2 identified in the venom of O. scutellatus: A6MFM9 and Q45Z48. Paradoxin is highlighted in gray. “*” --> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g005
Toxins 17 00488 g006
Figure 6. ClustalW alignment of OS1-homologous PLA2s identified in the venoms of O. scutellatus: Q45Z50, Q45Z45 and Q45Z51, and O. microlepidotus: Q45Z50, Q45Z45 and Q45Z51. OS1 is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 6. ClustalW alignment of OS1-homologous PLA2s identified in the venoms of O. scutellatus: Q45Z50, Q45Z45 and Q45Z51, and O. microlepidotus: Q45Z50, Q45Z45 and Q45Z51. OS1 is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g006
Toxins 17 00488 g007
Figure 7. ClustalW alignment of OS2-homologous PLA2s identified in the venoms of O. scutellatus: Q4VRI7, Q45Z47 and Q4VRI4, and O. microlepidotus: Q4VRI7, Q45Z49 and Q45Z41. OS2 is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 7. ClustalW alignment of OS2-homologous PLA2s identified in the venoms of O. scutellatus: Q4VRI7, Q45Z47 and Q4VRI4, and O. microlepidotus: Q4VRI7, Q45Z49 and Q45Z41. OS2 is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g007
Toxins 17 00488 g008
Figure 8. ClustalW alignment of Notexin-homologous PLA2 identified in the venom of O. scutellatus: Q9PUH0. Notexin is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 8. ClustalW alignment of Notexin-homologous PLA2 identified in the venom of O. scutellatus: Q9PUH0. Notexin is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g008
Toxins 17 00488 g009
Figure 9. ClustalW alignment of SNTX-1-homologous 3FTx identified in the venom of O. microlepidotus: A7X4S0. SNTX-1 is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 9. ClustalW alignment of SNTX-1-homologous 3FTx identified in the venom of O. microlepidotus: A7X4S0. SNTX-1 is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g009
Toxins 17 00488 g010
Figure 10. ClustalW alignment of Elapitoxin-Oh3a-homologous 3FTXs identified in the venoms of O. microlepidotus: A7X4R0, A8HDK8 and A7X4Q3, and O. scutellatus: A8HDK9. Elapitoxin-Oh3a is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 10. ClustalW alignment of Elapitoxin-Oh3a-homologous 3FTXs identified in the venoms of O. microlepidotus: A7X4R0, A8HDK8 and A7X4Q3, and O. scutellatus: A8HDK9. Elapitoxin-Oh3a is highlighted in gray. “*” -> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g010
Toxins 17 00488 g011
Figure 11. ClustalW alignment of Mambalgin-1-homologous 3FTxs identified in the venom of O. microlepidotus: A7X4T2, A7X4S7 and A8HDK2. Mambalgin-1 is highlighted in gray. “*”-> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Figure 11. ClustalW alignment of Mambalgin-1-homologous 3FTxs identified in the venom of O. microlepidotus: A7X4T2, A7X4S7 and A8HDK2. Mambalgin-1 is highlighted in gray. “*”-> fully conserved residues; “:” -> conservative substitution between residues; “.” -> semiconservative substitution between residues. Standard ClustalW color codes used for amino acid polarity/charge.
Toxins 17 00488 g011
Table 1. Identified proteins in the venom of O. microlepidotus by proteomic analysis.
Table 1. Identified proteins in the venom of O. microlepidotus by proteomic analysis.
FractionUNIPROT
Code		Theoretical Mass
(kDa) 1		−10lgPPeptidesUnique PeptidesProtein DescriptionType
3A7X4S06.79137.5788Short neurotoxin 3FTx-Oxy4 (O. microlepidotus)3FTx
4P0CB06 F46.7964.8931Short neurotoxin 2 (O. scutellatus)3FTx
B7S4N9 F5761.6833Kunitz-type protease inhibitor taicotoxin (O. scutellatus)Kunitz
B5G6G75.72119.781212Omwaprin-b (O. microlepidotus)Waprin
5A7X4R07.91137.9081Long neurotoxin 3FTx-Oxy2 (O. microlepidotus)3FTx
6Q45Z4914.3285.6341PLA-5 (O. scutellatus)PLA2
A8HDK87.98191.13161Long neurotoxin 2 (O. microlepidotus)3FTx
A7X4Q37.95188.04161Long neurotoxin 3FTx- Oxy1 (O. microlepidotus)3FTx
7Q45Z4114.22152.09124PLA-5 (O. microlepidotus)PLA2
8Q4VRI7 F814.3599.7251Alpha taipoxin-2 (O. scutellatus)PLA2
A7X4S76.28102.0544Toxin 3FTx- Oxy5 (O. microlepidotus)3FTx
Q3SAF84.11123.7166Natriuretic peptide OmNP-d (fragment) (O. microlepidotus)NP
9P00614 F913.83138.13126Basic phospholipase A2 taipoxin alpha chain (O. scutellatus)PLA2
A7X4T2 F126.87129.4866Three-finger Toxin 3FTx- Oxy6 (O. microlepidotus)3FTx
A8HDK2 F96.3466.9933Short neurotoxin 3 (O. scutellatus)3FTx
10Q45Z45 F915173.78186PLA-1 (O. microlepidotus)PLA2
Q45Z51F1014.95159.33122PLA-3 (O. microlepidotus)PLA2
P0CG5713.31115.2551Neutral phospholipase A2 homolog taipoxin beta chain 2 (O. microlepidotus)PLA2
11Q45Z46 F1013.33184.442210Neutral phospholipase A2 paradoxin-like beta chain (O. microlepidotus)PLA2
P00615 F1113.2399.2161Neutral phospholipase A2 homolog taipoxin beta chain 1 (O. scutellatus)PLA2
Q3HXZ0 F1013.39116.1755Venom nerve growth factor 2 (O. microlepidotus)NGF
Q3SB07 F1223.5583.5232Cysteine-rich venom protein pseudechetoxin-like (O. scutellatus)CRISP
12P00616 F1214.60214.032716Acidic phospholipase A2 homolog taipoxin gamma chain (O. scutellatus)PLA2
Q9PUH013.4453.5121Acidic phospholipase A2 S8-51 (Austrelaps superbus)PLA2
Q58L9515.9985.4133Venom prothrombin activator omicarin-C catalytic subunit (O. microlepidotus)PTA
P6004313.2163.0931Basic phospholipase A2 1 (Fragment) (Naja. Sagittifera)PLA2
13Q45Z50 F1315.21171.5552PLA-4 (O. scutellatus)PLA2
Q4VRI5 F914.10123.2141Phospholipase A2 OS1 (O. scutellatus)PLA2
A0A670YUG048.3174.98315′ nucleotidase ecto (Pseudonaja textilis)Nucleotidase
A0A2I4HXH557.8170.1331Snake venom 5′-nucleotidase (Naja atra)Nucleotidase
14A0A670Y1M6 F1453.81134.99126Prolylcarboxypeptidase (Pseudonaja textilis)Peptidase
A0A8C6XE7551.58107.0181Prolylcarboxipeptidase (Naja naja)Peptidase
V8NPH4 F1442.7675.5342Lysosomal Pro-X carboxypeptidase (Ophiophagus hannah)Peptidase
1 The theoretical mass was calculated by subtracting the mass of the signal peptide using the PeptideMass online software. F4, F5, F8–F14 Corresponds to the venom fraction (F) of O. scutellatus in which the same protein is present.
Table 2. Identified proteins in the venom of O. scutellatus by proteomic analysis.
Table 2. Identified proteins in the venom of O. scutellatus by proteomic analysis.
FractionUNIPROT
Code		Theoretical Mass
(kDa) 1		−10lgPPeptidesUnique PeptidesProtein DescriptionType
3Q45Z116.73122.2061Short neurotoxin 1 (O. scutellatus)3FTx
4P0CB06 F46.7994.7944Short neurotoxin 2 (O. scutellatus)3FTx
A8HDK97.8967.9455Long neurotoxin 1 (O. scutellatus)3FTx
5B7S4N9 F47142.3087Kunitz-type serine protease inhibitor taicotoxin (O. scutellatus)Kunitz
6P832283.6682.0333Natriuretic peptide TNP-b (O. scutellatus)NP
7Q45Z4713.33178.33142Phospholipase A2 OS2 (O. scutellatus)PLA2
Q4VRI414.2172.76141OS6 (O. scutellatus)PLA2
P1011613.3578.0941Basic phospholipase A2 2 (Laticauda colubrina)PLA2
A0A898INR614.7171.7221Phospholipase A (2) (Calliophis bivirgatus)PLA2
8Q4VRI7 F814.35157.86105Alpha taipoxin-2 (O. scutellatus)PLA2
Q45Z4814.59144.1372PLA-6 (O. scutellatus)PLA2
A6MFM914.52101.3832PLA2-4 (Crytophis nigrescens)PLA2
P1461513.4250.9721Neutral phospholipase A2 3 (Bungarus fasciatus)PLA2
9Q45Z45 F1015122.0271PLA-1 (O. microlepidotus)PLA2
P00614 F913.83179.92138Basic phospholipase A2 taipoxin alpha chain (O. scutellatus)PLA2
Q4VRI5 F1314.1172.67112Phospholipase A2 OS1 (O. scutellatus)PLA2
A6MFM914.5265.3132PLA2-4 (Crytophis nigrescens)PLA2
A8HDK2 F96.34102.6344Short neurotoxin 3 (O. scutellatus)3FTx
Q3SAX84.1196.4254Natriuretic peptide OsNP-d (fragment) (O. scutellatus)NP
10Q45Z46 F1113.33125.3283Neutral phospholipase A2 paradoxin-like beta chain (O. microlepidotus)PLA2
Q45Z51 F1014.95171.88105PLA-3 (O. scutellatus)PLA2
Q3HXZ0 F1113.3964.4233Venom nerve growth factor 2 (O. microlepidotus)NGF
11P00615 F1113.24170.01169Neutral phospholipase A2 homolog taipoxin beta chain 1 (O. scutellatus)PLA2
P0CG5713.31132.0491Neutral phospholipase A2 homolog taipoxin beta chain 2 (O. scutellatus)PLA2
Q3I5F413.3899.4244Venom nerve growth factor (O. scutellatus)NGF
12P00616 F1244.72172.56129Acidic phospholipase A2 homolog taipoxin gamma chain (O. scutellatus)PLA2
A7X4T2 F96.8783.1722Three-finger toxin 3FTx-Oxy6 (O. microlepidotus)3FTx
Q58L9644.69128.3066Venom prothrombin activator oscutarin-C catalytic subunit (O. scutellatus)PTA
Q3SB07 F1123.55151.14163Cysteine-rich venom protein pseudechetoxin-like (O. scutellatus)CRISP
Q8UW1124.5494.0571Cystein-rich venom protein 2 (Hydrophis hardwickii)CRISP
13Q45Z50 F1315.21135.4451PLA-4 (O. scutellatus)PLA2
Q58L91157.79200.61343Venom prothrombin activator oscutarin-C non catalytic subunit (O. scutellatus)PTA
14A0A670Y1M6 F1453.81130.34126Prolylcarboxypeptidase (Pseudonaja textilis)Peptidase
A0A8C6XDV954.70117.0881Prolylcarboxipeptidase (Naja naja)Peptidase
V8NPH4 F1442.7678.4542Lysosomal Pro-X carboxypeptidase (Ophiophagus hannah)Peptidase
1 The theoretical mass was calculated by subtracting the mass of the signal peptide using the PeptideMass software. F4, F8–F14 Corresponds to the venom fraction (F) of O. microlepidotus in which the same protein is present.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Paz, G.G.; Spencer, P.J.; Pimenta, D.C.; Beraldo-Neto, E. Exploring the Venom Diversity of Australian Taipans: Comparative Characterization of Oxyuranus microlepidotus and Oxyuranus scutellatus. Toxins 2025, 17, 488. https://doi.org/10.3390/toxins17100488

AMA Style

Paz GG, Spencer PJ, Pimenta DC, Beraldo-Neto E. Exploring the Venom Diversity of Australian Taipans: Comparative Characterization of Oxyuranus microlepidotus and Oxyuranus scutellatus. Toxins. 2025; 17(10):488. https://doi.org/10.3390/toxins17100488

Chicago/Turabian Style

Paz, Guilherme Gonelli, Patrick Jack Spencer, Daniel Carvalho Pimenta, and Emidio Beraldo-Neto. 2025. "Exploring the Venom Diversity of Australian Taipans: Comparative Characterization of Oxyuranus microlepidotus and Oxyuranus scutellatus" Toxins 17, no. 10: 488. https://doi.org/10.3390/toxins17100488

APA Style

Paz, G. G., Spencer, P. J., Pimenta, D. C., & Beraldo-Neto, E. (2025). Exploring the Venom Diversity of Australian Taipans: Comparative Characterization of Oxyuranus microlepidotus and Oxyuranus scutellatus. Toxins, 17(10), 488. https://doi.org/10.3390/toxins17100488

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop